Related Experiment Video
Updated: Aug 15, 2026

Measurement of Smooth Muscle Function in the Isolated Tissue Bath-applications to Pharmacology Research
Published on: January 19, 2015
Agonist-induced modulation of agonist binding to alpha 1-adrenoceptors in bovine aorta
G Jagadeesh1, W N Tian, R C Deth
1Section of Pharmacology, College of Pharmacy and Allied Health Professions, Northeastern University, Boston, MA 02115.
Abstract:
Prolonged exposure of tissues to hormone agonists results in a subsequent reduction in the sensitivity of the tissue through a process known as desensitization. The desensitization response, either homologous or heterologous, has been shown to be correlated with receptor phosphorylation. Recently we have provided evidence that protein kinase C, when activated by a phorbol ester, regulates alpha 1-adrenoceptor coupling to a G-protein. In the present study, the effects of epinephrine (10 microM) pretreatment on the binding behavior of the alpha 1-adrenoceptor were determined from radioligand binding assays at 25 degrees and 2 degrees C. Pretreatment of tissues with epinephrine for 25 min moderately decreased [3H]prazosin binding by 12% (Bmax 121.5 fmol/mg) in comparison to control (139.3 fmol/mg) with no change in its affinity. The second consequence of desensitization by epinephrine is a decrease in the affinity of agonist binding to alpha 1-adrenoceptors associated with uncoupling of the receptors from the G-protein. In control membranes, at 25 degrees C, epinephrine defined two different affinity states of the receptor, viz. high affinity (KDH 16.5 nM, % RH 21) and low affinity (KDL 710 nM, % RL 79). The high affinity state formed at 25 degrees C is stabilized by forming a ternary complex with a G-protein. Addition of guanylylimidodiphosphate (Gpp(NH)p) reduced the stability of this complex resulting in a loss of high affinity sites in control membranes. On the other hand, epinephrine treated membranes exhibited only a single class of low affinity agonist binding (KDH 659 nM) and further, Gpp(NH)p had no significant effect on binding.(ABSTRACT TRUNCATED AT 250 WORDS)
More Related Videos
Related Concept Videos
Adrenergic Receptors: ɑ Subtype
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase C—inositol-1,4,5-trisphosphate...
Adrenergic Receptors: β Subtype
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of the aromatic...
Adrenergic Antagonists: Chemistry and Classification of ɑ-Receptor Blockers
Nonselective α-blockers: Nonselective α-blockers contain haloalkylamine or imidazoline moieties. Phenoxybenzamine, with a haloalkylamine...
Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally, α1-blockers effectively address urinary obstruction...
Adrenergic Antagonists: ɑ and β-Receptor Blockers

